» Articles » PMID: 19108603

"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China

Overview
Journal PLoS Med
Specialty General Medicine
Date 2008 Dec 26
PMID 19108603
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Each year, 540 million Chinese are exposed to secondhand smoke (SHS), resulting in more than 100,000 deaths. Smoke-free policies have been demonstrated to decrease overall cigarette consumption, encourage smokers to quit, and protect the health of nonsmokers. However, restrictions on smoking in China remain limited and ineffective. Internal tobacco industry documents show that transnational tobacco companies (TTCs) have pursued a multifaceted strategy for undermining the adoption of restrictions on smoking in many countries.

Methods And Findings: To understand company activities in China related to SHS, we analyzed British American Tobacco's (BAT's) internal corporate documents produced in response to litigation against the major cigarette manufacturers to understand company activities in China related to SHS. BAT has carried out an extensive strategy to undermine the health policy agenda on SHS in China by attempting to divert public attention from SHS issues towards liver disease prevention, pushing the so-called "resocialisation of smoking" accommodation principles, and providing "training" for industry, public officials, and the media based on BAT's corporate agenda that SHS is an insignificant contributor to the larger issue of air pollution.

Conclusions: The public health community in China should be aware of the tactics previously used by TTCs, including efforts by the tobacco industry to co-opt prominent Chinese benevolent organizations, when seeking to enact stronger restrictions on smoking in public places.

Citing Articles

Association between tobacco exposure and bladder cancer recurrence: A systematic review and meta-analysis.

Xiang L, Xie Q, Xu S, Ruan W, Xu D, Gan Y World J Methodol. 2024; 14(2):91889.

PMID: 38983655 PMC: 11229875. DOI: 10.5662/wjm.v14.i2.91889.


Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy.

Ulucanlar S, Lauber K, Fabbri A, Hawkins B, Mialon M, Hancock L Int J Health Policy Manag. 2023; 12:7292.

PMID: 37579378 PMC: 10462073. DOI: 10.34172/ijhpm.2023.7292.


Tobacco industry globalization and global health governance: towards an interdisciplinary research agenda.

Lee K, Eckhardt J, Holden C Palgrave Commun. 2017; 2.

PMID: 28458910 PMC: 5409523. DOI: 10.1057/palcomms.2016.37.


Analysis of British American Tobacco's questionable use of privilege and protected document claims at the Guildford Depository.

LeGresley E, Lee K Tob Control. 2016; 26(3):316-322.

PMID: 27354678 PMC: 5520244. DOI: 10.1136/tobaccocontrol-2016-052955.


'Public enemy no. 1': Tobacco industry funding for the AIDS response.

Smith J, Thompson S, Lee K SAHARA J. 2016; 13:41-52.

PMID: 27023371 PMC: 5068916. DOI: 10.1080/17290376.2016.1164617.


References
1.
Muggli M, Hurt R . Tobacco industry strategies to undermine the 8th World Conference on Tobacco or Health. Tob Control. 2003; 12(2):195-202. PMC: 1747698. DOI: 10.1136/tc.12.2.195. View

2.
Chen M . Economic concerns hamper tobacco control in China. Lancet. 2007; 370(9589):729-30. DOI: 10.1016/S0140-6736(07)61359-2. View

3.
Balbach E, Gasior R, Barbeau E . Tobacco industry documents: comparing the Minnesota Depository and internet access. Tob Control. 2002; 11(1):68-72. PMC: 1747640. DOI: 10.1136/tc.11.1.68. View

4.
Yang G, Ma J, Liu N, Zhou L . [Smoking and passive smoking in Chinese, 2002]. Zhonghua Liu Xing Bing Xue Za Zhi. 2005; 26(2):77-83. View

5.
Tong E, Glantz S . ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia. Tob Control. 2004; 13 Suppl 2:ii118-24. PMC: 1766165. DOI: 10.1136/tc.2004.009001. View